ALPS Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $335K | Buy |
10,601
+128
| +1% | +$4.05K | ﹤0.01% | 896 |
|
|
2025
Q1 | $348K | Buy |
10,473
+1,229
| +13% | +$40.8K | ﹤0.01% | 805 |
|
|
2024
Q4 | $318K | Hold |
9,244
| – | – | ﹤0.01% | 855 |
|
|
2024
Q3 | $370K | Sell |
9,244
-1,984
| -18% | -$79.4K | ﹤0.01% | 744 |
|
|
2024
Q2 | $339K | Sell |
11,228
-59
| -0.5% | -$1.78K | ﹤0.01% | 767 |
|
|
2024
Q1 | $379K | Buy |
11,287
+2,895
| +34% | +$97.2K | ﹤0.01% | 665 |
|
|
2023
Q4 | $271K | Sell |
8,392
-478
| -5% | -$15.4K | ﹤0.01% | 906 |
|
|
2023
Q3 | $291K | Buy |
+8,870
| New | +$291K | ﹤0.01% | 893 |
|
|
2023
Q1 | – | Sell |
-6,880
| Closed | -$379K | – | 1074 |
|
|
2022
Q4 | $379K | Sell |
6,880
-27
| -0.4% | -$1.49K | ﹤0.01% | 698 |
|
|
2022
Q3 | $306K | Buy |
+6,907
| New | +$306K | ﹤0.01% | 751 |
|